EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Dilemmas in the diagnosis and management of antiphospholipid syndrome

James E Manning, Deepa J Arachchillage

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.03.027 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von James E Manning und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Imperi…. Hauptthemen laut MEDLINE: Antibodies, Antiphospholipid, Anticoagulants, Antiphospholipid Syndrome. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiphospholipid syndrome (APS) is characterized by thrombosis (which may be venous, arterial, or microvascular) and/or pregnancy morbidity in association with persistently positive antiphospholipid antibodies. Although thrombosis and pregnancy morbidity are the main clinical criteria for a diagnosis of APS in the revised Sapporo (Sydney) criteria, recently published American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for APS have significantly refined the diagnostic algorithm to include a scoring system clustered into 6 clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular thrombosis, obstetric, cardiac valve, and hematologic). Diagnosis of APS is complicated by the fact that significant heterogeneity exists in patients' clinical presentation, underlying vascular risk factors, and methods of detecting antiphospholipid antibodies. Despite the autoimmune nature of APS, anticoagulation remains the main strategy for secondary prevention of thrombosis. Furthermore, optimal antithrombotic treatment in APS patients with arterial thrombosis remains controversial due to a paucity of data from randomized controlled studies. In this paper, we present 2 cases and highlight the diagnostic and therapeutic challenges they pose and how we approach them in the light of current evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntiphospholipidAnticoagulantsAntiphospholipid SyndromeFemaleHumansMalePregnancyPredictive Value of TestsRisk FactorsThrombosisTreatment Outcome

Stichwörter der Autor:innen

anticoagulationantiphospholipid antibodiesantiphospholipid syndromepregnancy morbiditythrombosis

Substanzen

Antibodies, AntiphospholipidAnticoagulants

Autor:innen und Institutionen

  • Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom. Electronic ad…

Förderung

  • Medical Research Council

Zitieren

APA

Manning, J. E., & Arachchillage, D. J. (2024). Dilemmas in the diagnosis and management of antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.03.027

Vancouver

Manning JE, Arachchillage DJ. Dilemmas in the diagnosis and management of antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.03.027

BibTeX
@article{Manning2024,
  author = {Manning, James E and Arachchillage, Deepa J},
  title = {Dilemmas in the diagnosis and management of antiphospholipid syndrome},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.03.027}
}
Kostenlos starten →